Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation.

Fatouh AM, Elshafeey AH, Abdelbary A.

Drug Deliv. 2017 Nov;24(1):1077-1085. doi: 10.1080/10717544.2017.1357148.

PMID:
28745530
2.

Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics.

Fatouh AM, Elshafeey AH, Abdelbary A.

Drug Des Devel Ther. 2017 Jun 19;11:1815-1825. doi: 10.2147/DDDT.S102500. eCollection 2017.

3.

Assessment of serum level of corticotropin-releasing factor in primary nocturnal enuresis.

Motawie AA, Abd Al-Aziz AM, Hamed HM, Fatouh AA, Awad MA, El-Ghany AA.

J Pediatr Urol. 2017 Feb;13(1):46.e1-46.e5. doi: 10.1016/j.jpurol.2016.08.030. Epub 2016 Oct 24.

PMID:
27887910
4.

Exposure assessment of Malondialdehyde, 4-Hydroxy-2-(E)-Nonenal and 4-Hydroxy-2-(E)-Hexenal through specific foods available in Belgium.

Papastergiadis A, Fatouh A, Jacxsens L, Lachat C, Shrestha K, Daelman J, Kolsteren P, Van Langenhove H, De Meulenaer B.

Food Chem Toxicol. 2014 Nov;73:51-8. doi: 10.1016/j.fct.2014.06.030. Epub 2014 Jul 14.

PMID:
25035169
5.

Anti-diuretic hormone and genetic study in primary nocturnal enuresis.

Fatouh AA, Motawie AA, Abd Al-Aziz AM, Hamed HM, Awad MA, El-Ghany AA, El Bassyouni HT, Shehab MI, Eid MM.

J Pediatr Urol. 2013 Dec;9(6 Pt A):831-7. doi: 10.1016/j.jpurol.2012.11.009. Epub 2012 Dec 14.

PMID:
23246575
6.

Scoring systems in high risk pregnancy.

Fatouh AA, Fakhr MM.

J Egypt Soc Obstet Gynecol. 1991 Jan;17(1):19-26.

PMID:
12317329

Supplemental Content

Loading ...
Support Center